About UCSF Search UCSF UCSF Medical Center

News

image

Susan Desmond-Hellmann Named UC San Francisco Chancellor

May 7, 2009

Susan Desmond-Hellmann, a physician, pioneering cancer researcher and biotechnology industry executive who most recently served as president of product development for Genentech, today (May 7) was named chancellor of the University of California, San Francisco campus by the University of California Board of Regents. The ...
image

UCSF Study Shows Attitudes toward Tobacco Industry Linked to Smoking Behavior

May 6, 2009

A new study by UCSF researchers concludes that media campaigns that portray the tobacco industry in a negative light and that appeal to young adults may be a powerful intervention to decrease young adult smoking. The study sheds light on the relationship between attitudes toward ...
image

UC President Announces Recommended Candidates for Chancellors of UC Davis, UC San Francisco

May 1, 2009

University of California President Mark G. Yudof will bring the names of two candidates to serve as chancellors of UC Davis and UC San Francisco to next week's meeting of the UC Board of Regents, the university announced today (May 1). Both appointments are subject ...
image

Cancer-causing Virus Associated with Higher Risk of New HIV Infection

April 30, 2009

Infection with anal human papillomavirus (HPV), a virus that can cause anal and cervical cancers, is associated with a higher risk of new HIV infection in previously HIV-negative men who have sex with men (MSM), according to new UCSF research. Reported online ahead of print ...
image

Imaging Lab Draws from Impressive Arsenal to Fight Major Health Threats

April 30, 2009

Surrounded by cutting-edge equipment most people couldn't even turn on, much less operate, researchers at a UCSF imaging laboratory are using innovative techniques to study and improve the treatment of life-altering medical conditions, from cancer to multiple sclerosis and Alzheimer's disease. The Margaret Hart Surbeck ...
image

UCSF Oncologist Led Early Clinical Trials of Provenge

April 28, 2009

Prostate cancer patients who have advanced disease that no longer responds to hormone-blocking therapy might become the first to benefit from a new type of cancer drug. With these new immunotherapies, the patients' own immune cells are supercharged to better fight the disease, says a ...